Mr. Andrea Young reports
MEDMIRA BRINGS FIRST COMPREHENSIVE POINT-OF-CARE RAPID HIV TEST TO MEXICO
MedMira Inc. has received approval from the Federal Commission for the Protection
against Sanitary Risk (COFEPRIS) to market and sell its Reveal rapid HIV antibody test (Reveal HIV) in Mexico. Reveal HIV is the first rapid HIV test to be
approved and sold in Mexico that is available in an all-inclusive
point-of-care format. This comprehensive kit for point-of-care testing
includes everything necessary to conduct the test anywhere, any time, and
delivers more operational and cost-efficiencies to care providers and
their patients than any other test on the market.
In addition to the point-of-care format, MedMira's distribution partner
in Mexico, Diagno Medical, will also sell Reveal HIV in two laboratory
formats to optimize user needs in all testing environments, from the
laboratory to the point of care. Built on MedMira's patented rapid vertical flow technology, Reveal HIV delivers result instantly with a simple three-step
procedure, making it the fastest available test on the market. Other
rapid tests on the market take anywhere from 15 to 40 minutes to
deliver a result, while Reveal HIV takes less than two minutes from go
to know. The Reveal HIV test is an easy-to-use, first-line-of-defence
tool to prevent the spread of HIV infection.
The AIDS Healthcare Foundation (AHF) indicates that the country's
infection rate has remained about the same in the past decade with
220,000 people currently living with HIV in Mexico. More than 30
per cent of the 110 million people living in Mexico are located in
suburban areas where HIV testing and treatment are not easily accessible,
forcing people to travel to urban areas if they wish to be tested.
"The availability of the Reveal HIV provides patients with more options
for screening, particularly those in suburban areas," said Roger
Cornejo, chief executive officer of Diagno Medical. "The absence of quality point-of-care
HIV testing and care across the country has contributed to the lack of
success in decreasing infection rates. Now we can make screening safer,
faster and more accessible with Reveal HIV, and offer the right tool to
aid in the fight against the spread of HIV infection across Mexico."
The Reveal HIV test provides patients with more options for screening
including doctor's office and small remote clinics outside of urban
areas. The compact, lightweight package provides all of the components
needed for whole blood testing at the point of care, including lancet,
alcohol swab and a leak-proof test cartridge. With everything included
in a single package, care providers do not need to order, stock and
manage inventory of various accessories to perform point-of-care whole
blood testing.
The approval of Reveal HIV in Mexico is one of several that MedMira has
recently achieved in Latin America. The company is also pursuing
product approvals for the Reveal and Multiplo ranges in Panama,
Ecuador, Brazil and Argentina as part of its continuing expansion in the
region.
We seek Safe Harbor.
© 2024 Canjex Publishing Ltd. All rights reserved.